Cleared Traditional

K201467 - Blood Pressure Monitor-Model 2005

K201467 is an FDA 510(k) clearance for Blood Pressure Monitor-Model 2005, manufactured by Bioland Technology, Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 111-day FDA review.

K201467 · Bioland Technology, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
111d
Days
Class 2
Risk

K201467 is an FDA 510(k) clearance for the Blood Pressure Monitor-Model 2005, 2006-2, 2006-2B. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Bioland Technology, Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on September 21, 2020 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Bioland Technology, Ltd. devices

FDA 510(k) Submission Details - K201467

510(k) Number K201467 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2020
Decision Date September 21, 2020
Days to Decision 111 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 125d · This submission: 111d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 566
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K201467.
InBody
K200442 · Inbody Co., Ltd. · Dec 2020
Electronic Blood Pressure Monitor
K200716 · Shenzhen Pango Electronic Co., Ltd. · Dec 2020
V20, V20a, AVSM3 SNF
K200434 · Mediana Co., Ltd. · Oct 2020
Electronic Blood Pressure Monitor
K200939 · Jiangsu Yuyue Medical Equipment& Supply Co., Ltd. · Aug 2020
Arm-Type Fully Automatic Digital Blood Pressure Monitor
K200649 · Joytech Healthcare Co. , Ltd. · Aug 2020
Microlife Upper Arm Automatic Digital Blood Pressure Monitor
K200738 · Microlife Intellectual Property GmbH · Jul 2020